FOLFOX for Stage II Colon Cancer? A Commentary on the Recent FDA Approval of Oxaliplatin for Adjuvant Therapy of Stage III Colon Cancer-Reference-Cited by-同舟云学术

FOLFOX for Stage II Colon Cancer? A Commentary on the Recent FDA Approval of Oxaliplatin for Adjuvant Therapy of Stage III Colon Cancer

Published:2005-05-20 Issue:15 Volume:23 Page:3311-3313
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Grothey Axel¹,Sargent Daniel J.²

Affiliation:

1. Mayo Clinic College of Medicine, Departments of Medical Oncology, Rochester, MN

2. Mayo Clinic College of Medicine, Health Science Research, Rochester, MN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.11.691

Reference19 articles.

1. Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

2. Adjuvant Therapy for Patients With Colon and Rectal Cancer

3. Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

4. de Gramont A, Boni C, Navarro M, et al: Oxaliplatin/5-FU/LV in stage II and III colon cancer: Updated results (as of January 04) for efficacy and neurotoxicity of the MOSAIC trial. Ann Oncol 15:III73,2004, (abstr 275PD; suppl 3)

5. Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer;Journal of Clinical Oncology;2016-10-20

2. Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer;World Journal of Gastroenterology;2016

3. Do Statins Really Improve Colorectal Cancer–Specific Mortality?;Journal of Clinical Oncology;2015-03-01

4. Cost–Utility Analysis of Chemotherapy Regimens in Elderly Patients with Stage III Colon Cancer;PharmacoEconomics;2014-06-12

5. Which is false: Oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody;Cancer Science;2013-07-30